The MyoMobile study will explore the UMANA T1 Heart Monitor, a novel real-time remote cardiac monitoring device. MyoMobile is a prospective, randomized study investigating the effect of a personalized mobile health intervention on the physical activity levels in patients with heart failure
Latest news
Investor
23.04.2025
Q1 2025: €15 million in new international contracts
The Group strengthens its international position
Events
18.04.2025
Gpi Automation Exchange Days
In Bologna, the international team and global partners gather to strengthen collaboration
ESG
15.04.2025
Gpi’s commitment to an ever more responsible future continues
The 2024 Consolidated Sustainability Statement has been published
